Voxar Limited
United KingdomFDA 510(k) applicant, unverified
- Devices
- 4
What Voxar Limited makes
Voxar Limited manufactures computed tomography (CT) imaging software tools for coronary artery calcium scoring and 3D visualization of cardiac structures. The VOXAR 3D Product Family includes automated analysis and rendering solutions, while the Calcium Scoring Product focuses on quantifying coronary artery plaque. The PLUG 'N VIEW 3D and VOXAR VC (Model 1.0) provide post-processing and analysis capabilities for cardiac imaging data.
The company’s products are classified as Class II medical devices under FDA regulations and are supported by 510(k) clearances. These tools are designed for integration with CT scanners to assist in cardiovascular diagnostics. Voxar Limited is based in the United States.
Catalogue
Voxar 3D Product Family Ref K043194
510(k) 510(k)Voxar's Calcium Scoring Product Ref K020140
510(k) 510(k)Voxar Vc, Model 1.0 Ref K012072
510(k) 510(k)Plug 'n View 3D, Version 1.0 Ref K992654
510(k) 510(k)
Frequently asked questions
How many devices does Voxar Limited have in the registry?
The registry currently lists 4 devices for Voxar Limited. Devices recorded under merged duplicate company entries are counted once.
Which registries list Voxar Limited's devices?
Among its 4 most recently registered devices, Voxar Limited has devices listed in FDA 510(k) (4 devices).
What risk classes do Voxar Limited's devices fall under?
Among its 4 most recently registered devices, the classes recorded for Voxar Limited's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Voxar Limited in the registry?
The most recently registered devices listed for Voxar Limited include VOXAR 3D PRODUCT FAMILY, VOXAR'S CALCIUM SCORING PRODUCT, VOXAR VC, MODEL 1.0 and PLUG 'N VIEW 3D, VERSION 1.0.